Breast Cancer Research Foundat is a Organizations business in Birmingham, AL.
Business Name: | Breast Cancer Research Foundat |
Categorized In: | Organizations |
Address: | 1802 6th Avenue South, Birmingham, AL 35233 |
Phone Number: | (205) 298-1234 |
Contact Person: | Alan Register |
NAICS Code: | 813410 |
SIC Code: | 8699 |
Business Type: | B2B & B2C |
Founding Year: | 2010 |
Employee #: | 1 to 4 |
Location Type: | Single Location |
Annual Revenue ($): | $500.000 to $999.999 |
Share This Business: | |
Similar Businesses: |
University - Birmingham, AL 35233 Partners in Neighborhood Grwth - Birmingham, AL 35233 Map Inc - Birmingham, AL 35233 Shores Fred H Educ Sholarship - Birmingham, AL 35233 Women's Fund-Greater Brmnghm - Birmingham, AL 35233 Lorie Johnson Charitable Remainder Trust - Birmingham, AL 35233 Dennis G Pappas Sr Family Fdtn - Birmingham, AL 35233 Whatley Charitable Trust - Birmingham, AL 35233 Demeco Ryans Foundation - Birmingham, AL 35233 Alabama Children's Hosp Foundation - Birmingham, AL 35233 |
Breast Cancer Research Foundat, a stable growing company under Organizations, is being run by Alan Register. Since , their sales have been favorable and consistent at $500.000 to $999.999. Company location coordinates are: 33.506084,-86.8029.
It can be reached by dialing (205) 298-1234, and you could get in touch with their sales team in 1802 6th Avenue South, Birmingham, Alabama AL 35233. Visit their website at: to know more about the company’s history, products and services, as well as frequently asked questions and privacy policies.
Special deals are also offered from time to time. Their professional and honest business transactions fortifies both consumers and businesses in their BOTH segments.
Their modest but solid single location houses 1 to 4 staff members. All are benefiting from the company’s generous programs and sound training solutions.
You can learn more by checking their classification codes: SIC – 8699 and NAIC – 813410. Call the hotline stated above for faster transaction and queries. Breast Cancer Research Foundat would like to hear from you.